News | Mammography | September 17, 2015

KLAS Research finds Hologic stands out among mammography providers for technology innovation, high image quality and C-View dose-reduction technology

Hologic, Genius 3-D Mammography, KLAS Research, U.S. breast tomosynthesis market, C-View

Selenia Dimensions system with Genius 3-D Mammography image courtesy of Hologic.
 


September 17, 2015 — Hologic Inc. announced that U.S. mammography providers gave the company and its Genius 3-D Mammography exams top scores in a new study by KLAS Research, titled Women’s Imaging 2015: Are New Technologies Delivering Promised Benefits?

In the study, mammography providers scored Hologic highest in all 11 performance measures evaluated by KLAS.  For example:

  • 95 percent of users said they would buy from Hologic again; and
  • 67 percent of users said Hologic was their best mammography vendor.

The researchers noted that Hologic 3-D Mammography stands out for technology innovation and high image quality, and that its C-View software is strengthening satisfaction and encouraging adoption. 

The KLAS study found significant movement in the mammography space thanks to the advent of breast tomosynthesis technology. For example, 65 percent of the providers surveyed planned to invest in breast tomosynthesis technology during the next two years, up from 57 percent in 2014. The study notes that many respondents who said they did not intend to purchase had already upgraded to tomosynthesis.

Clinical studies have shown that a Hologic Genius 3-D Mammography exam using the company’s low-dose software is superior to 2-D exams alone for all breast types, improving diagnostic accuracy while also reducing recalls. With C-View software, facilities can offer a better exam at an equivalent dose to 2-D alone.

For more information: www.hologic.com


Related Content

News | Women's Health

March 4, 2026 — QT Imaging Holdings recently announced that Mary W. Yamashita, MD will serve as medical advisor to the ...

Time March 06, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | Women's Health

Feb.23, 2026 — The first clinical patient received a Clairity Breast cancer risk score, marking a historic milestone in ...

Time February 23, 2026
arrow
News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
Subscribe Now